blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1351668

EP1351668 - SUSTAINED RELEASE PHARMACEUTICAL DOSAGE FORMS WITH MINIMIZED PH DEPENDENT DISSOLUTION PROFILES [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  21.08.2015
Database last updated on 12.10.2024
Most recent event   Tooltip21.08.2015No opposition filed within time limitpublished on 23.09.2015  [2015/39]
Applicant(s)For all designated states
Supernus Pharmaceuticals, Inc.
1550 East Gude Drive
Rockville, MD 20850 / US
[2006/33]
Former [2003/42]For all designated states
Shire Laboratories Inc.
1550 East Gude Drive
Rockville, Maryland 20850 / US
Inventor(s)01 / BURNSIDE, Beth
18613 Tanterra Way
Brookeville, MD 20833 / US
02 / CHANG, Rong-Kun
13607 Pine View Lane
Rockville, MD 20850 / US
03 / GUO, Xiaodi
22 Hallmark Dr
New City, NY 10956 / US
 [2003/42]
Representative(s)Walcher, Armin
Louis Pöhlau Lohrentz
Patentanwälte Partnerschaft mbB
Merianstraße 26
90409 Nürnberg / DE
[N/P]
Former [2014/42]Walcher, Armin
Louis, Pöhlau, Lohrentz
Patentanwälte
Postfach 30 55
90014 Nürnberg / DE
Former [2003/42]Walcher, Armin
Louis, Pöhlau, Lohrentz & Segeth Postfach 3055
90014 Nürnberg / DE
Application number, filing date01998126.520.12.2001
[2003/42]
WO2001US50773
Priority number, dateUS2000074154820.12.2000         Original published format: US 741548
[2003/42]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO02058676
Date:01.08.2002
Language:EN
[2002/31]
Type: A1 Application with search report 
No.:EP1351668
Date:15.10.2003
Language:EN
The application published by WIPO in one of the EPO official languages on 01.08.2002 takes the place of the publication of the European patent application.
[2003/42]
Type: B1 Patent specification 
No.:EP1351668
Date:15.10.2014
Language:EN
[2014/42]
Search report(s)International search report - published on:US01.08.2002
(Supplementary) European search report - dispatched on:EP03.01.2007
ClassificationIPC:A61K9/22
[2003/42]
CPC:
A61K9/2027 (EP,US); A61K9/2009 (EP,US); A61K9/2013 (EP,US);
A61K9/2031 (EP,US); A61K9/205 (EP,US); A61K9/2054 (EP,US);
A61P25/28 (EP); A61P35/02 (EP); A61P7/00 (EP) (-)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   TR [2003/42]
TitleGerman:PHARMAZEUTISCHE RETARDDOSIERUNGSFORMEN MIT MINIMIERTEN PH-ABHÄNGIGEN AUFLÖSUNGSVERLÄUFEN[2003/42]
English:SUSTAINED RELEASE PHARMACEUTICAL DOSAGE FORMS WITH MINIMIZED PH DEPENDENT DISSOLUTION PROFILES[2003/42]
French:FORMES DE DOSAGE PHARMACEUTIQUE A LIBERATION PROLONGEE POSSEDANT DES PROFILES DE DISSOLUTION A DEPENDANCE AU PH REDUITE AU MINIMUM[2003/42]
Entry into regional phase26.06.2003National basic fee paid 
26.06.2003Search fee paid 
26.06.2003Designation fee(s) paid 
26.06.2003Examination fee paid 
Examination procedure19.07.2002Request for preliminary examination filed
International Preliminary Examining Authority: US
26.06.2003Examination requested  [2003/42]
08.02.2007Amendment by applicant (claims and/or description)
18.06.2008Despatch of a communication from the examining division (Time limit: M06)
22.12.2008Reply to a communication from the examining division
07.12.2010Despatch of a communication from the examining division (Time limit: M06)
08.06.2011Reply to a communication from the examining division
16.05.2012Despatch of a communication from the examining division (Time limit: M04)
21.09.2012Reply to a communication from the examining division
09.10.2012Despatch of a communication from the examining division (Time limit: M04)
13.02.2013Reply to a communication from the examining division
09.04.2013Despatch of a communication from the examining division (Time limit: M04)
08.07.2013Reply to a communication from the examining division
19.09.2013Communication of intention to grant the patent
20.01.2014Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
05.06.2014Communication of intention to grant the patent
11.06.2014Receipt of the translation of the claim(s)
04.09.2014Fee for grant paid
04.09.2014Fee for publishing/printing paid
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  18.06.2008
Opposition(s)16.07.2015No opposition filed within time limit [2015/39]
Fees paidRenewal fee
29.12.2003Renewal fee patent year 03
23.12.2004Renewal fee patent year 04
27.12.2005Renewal fee patent year 05
27.12.2006Renewal fee patent year 06
24.12.2007Renewal fee patent year 07
24.12.2008Renewal fee patent year 08
28.12.2009Renewal fee patent year 09
27.12.2010Renewal fee patent year 10
27.12.2011Renewal fee patent year 11
26.12.2012Renewal fee patent year 12
27.12.2013Renewal fee patent year 13
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Rights in Rem or Legal Means of ExecutionID:01
For:AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR
Date:12.03.2014
[2014/18]
Documents cited:Search[X]EP0320097  (ELAN CORP PLC [IE]) [X] 1-73 * examples 1,4,6 * * claims 1,6-9 *;
 [X]EP0373417  (SCHERING CORP [US]) [X] 1-73 * example 7 * *claims*;
 [X]US5229135  (PHILIPPON FRANCIS [FR], et al) [X] 1-73 * column 6, line 53 - column 7, line 30 * * claims 1-3 *;
 [X]WO9920223  (NOVO NORDISK AS [DK], et al) [X] 8,9,49,50,60,65 * page 17, line 17 - line 25 ** claims 1,8 *;
 [X]WO9921551  (UNIV TEMPLE [US]) [X] 1-73 * page 1, line 3 - line 9 * * examples 1,2 * * claims 1-7 *;
 [X]WO0041681  (GRUENENTHAL GMBH [DE], et al) [X] 6,7,70-73 * page 9, line 24 - line 27 * * examples 3,4 * * claims 1,7,8 *
International search[A]US4968508  (OREN PETER L [US], et al);
 [A]US5102668  (EICHEL HERMAN J [US], et al);
 [A]US5378474  (MORELLA ANGELO M [AU], et al)
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.